scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "neoadjuvant chemotherapy"

1 - 10 of 21,209 results for
 "neoadjuvant chemotherapy"
Results per page:

Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial.

Publication Type: Academic Journal

Source(s): Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Sep; Vol. 21 (3), pp. e196-e204. Date of Electronic Publication: 2022 May 13.

Abstract: INDUCTION: chemotherapy (IC) followed by chemoradiation (CRT) is an attractive approach in high-risk locally advanced rectal cancer. Additionally, ASA has shown potential to improve outcomes alongside CRT in rectal cancer. The ICAR trial aimed to evalu...

View details

Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy.

Publication Type: Academic Journal

Source(s): Frontiers in immunology [Front Immunol] 2022 Jul 14; Vol. 13, pp. 953229. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).

Authors:

Abstract: Background: Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer in China. The use of neoadjuvant immunotherapy for the treatment of ESCC is gradually increasing. Camrelizumab is one such immune checkpoint inhibitor (I...

View details

Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?

Publication Type: Academic Journal

Source(s): Cancer treatment reviews [Cancer Treat Rev] 2022 Nov; Vol. 110, pp. 102454. Date of Electronic Publication: 2022 Aug 11.

Abstract: Neoadjuvant chemotherapy (NACT) for breast cancer (BC) increases surgical and conservative surgery chances. However, a significant proportion of patients will not be eligible for conservative surgery following NACT because of large tumor size and/or lo...

View details

Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers.

Publication Type: Academic Journal

Source(s): European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 181-188. Date of Electronic Publication: 2022 Sep 28.

Abstract: Background: Half of HER2-negative breast cancers (BC) show HER2-low expression. The strong efficacy of recent anti-HER2 antibody-drug conjugates (ADC) in HER2-low tumours has risen the interest of HER2-low as a proper BC subtype. Chemosensitivity and p...

View details

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis.

Publication Type: Academic Journal

Source(s): Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Oct 22; Vol. 58 (11). Date of Electronic Publication: 2022 Oct 22.

Authors:

Abstract: Background and Objectives : Increasing evidence supports the use of neoadjuvant chemotherapy (NAC) for locally advanced colon cancer (LACC). However, its effectiveness remains controversial. This study explored the safety and efficacy of NAC combined w...

View details

Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.

Publication Type: Academic Journal

Source(s): Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2022 Nov; Vol. 25 (6), pp. 1039-1049. Date of Electronic Publication: 2022 Aug 03.

Authors:

Abstract: Background: In this post hoc analysis of the PRODIGY study, we aimed to investigate factors associated with survival outcomes and provide evidence for designing optimal perioperative treatment strategies for gastric cancer patients receiving neoadjuvan...

View details

Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs).

Publication Type: Academic Journal

Source(s): Anticancer research [Anticancer Res] 2022 Mar; Vol. 42 (3), pp. 1421-1431.

Abstract: Background/aim: Tumor-infiltrating lymphocytes (TILs), which are indicators of immune response monitoring, are generally mononuclear immunocytes that aggregate with tumors and are thought to have a close relationship with cancer cells. On the other han...

View details

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer.

Publication Type: Academic Journal

Source(s): Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Nov 01; Vol. 23 (11), pp. 3641-3647. Date of Electronic Publication: 2022 Nov 01.

Abstract: Introduction: In regards to resectable muscle-invasive bladder cancer (MIBC) patients, contemporary guidelines recommend treatment with radical cystectomy and perioperative chemotherapy (neoadjuvant or adjuvant). In addition, the 5-year survival rate r...

View details

The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis.

Publication Type: Academic Journal

Source(s): European journal of radiology [Eur J Radiol] 2022 Dec; Vol. 157, pp. 110561. Date of Electronic Publication: 2022 Oct 17.

Abstract: Background: Achieving pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) improves survival outcomes for breast cancer patients. Currently, conventional histopathological biomarkers predicting such responses are inconsistent. Studies...

View details

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Publication Type: Academic Journal

Source(s): Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 2581-2597.

Authors:

Abstract: Propose: Neoadjuvant chemotherapy has been widely used in locally advanced and inflammatory breast cancer. Generally, complete pathological response after neoadjuvant chemotherapy treatment predicts survival. Studies have shown that patient-derived org...

View details
sponsored